Dr. Rose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6709 Kenhill Rd
Bethesda, MD 20817Phone+1 301-229-8673Fax+1 301-229-8674
Education & Training
St Mary's Hospital and Medical CenterResidency, Internal Medicine, 1973 - 1974- St Marys Hospital and Medical CenterInternship, Transitional Year, 1971 - 1972
University of California San Francisco School of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1972 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 4 citationsHeart Failure Population with Therapeutic Response to Sacubitril/Valsartan, Spironolactone and Candesartan: FDA Perspective.Charu Gandotra, Jennifer Clark, Ququan Liu, Fortunato Senatore, Martin Rose
Therapeutic Innovation & Regulatory Science. 2021-10-26 - Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.Fortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, Venkateswaran C Pillai, Sudharshan Hariharan
American Journal of Cardiovascular Drugs. 2019-03-01 - 29 citationsFDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.Fortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, Venkateswaran C Pillai, Sudharshan Hariharan
American Journal of Cardiovascular Drugs. 2019-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
